Insider Trading Alert - PRAA, MLNX And ARUN Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 25, 2014, 122 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $95.53 to $95,971,341.22.

Highlighted Stocks Traded by Insiders:

Portfolio Recovery Associates (PRAA) - FREE Research Report

Graves Christopher B who is EVP, Core Acquisitions at Portfolio Recovery Associates sold 7,271 shares at $58.00 on Feb. 25, 2014. Following this transaction, the EVP, Core Acquisitions owned 46,095 shares meaning that the stake was reduced by 13.62% with the 7,271-share transaction.

The shares most recently traded at $55.01, down $2.99, or 5.44% since the insider transaction. Historical insider transactions for Portfolio Recovery Associates go as follows:

  • 4-Week # shares sold: 34,100
  • 12-Week # shares sold: 45,000
  • 24-Week # shares sold: 74,036

The average volume for Portfolio Recovery Associates has been 616,700 shares per day over the past 30 days. Portfolio Recovery Associates has a market cap of $2.8 billion and is part of the services sector and diversified services industry. Shares are up 7.06% year-to-date as of the close of trading on Tuesday.

Portfolio Recovery Associates, Inc., a financial and business service company, engages in the purchase, collection, and management of portfolios of defaulted consumer receivables in the United States and the United Kingdom. The company has a P/E ratio of 16.4. Currently there are 4 analysts that rate Portfolio Recovery Associates a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRAA - FREE

TheStreet Quant Ratings rates Portfolio Recovery Associates as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Portfolio Recovery Associates Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Insiders Love Bioverativ, Juno Therapeutics and More

Sell These 5 Stocks Now Before They Turn Toxic

PRA Group (PRAA) Flagged As Strong On High Volume

Insider Trading Alert - CNBKA, PRAA And SIG Traded By Insiders

PRA Group (PRAA) Weak On High Volume